We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Tiny Device in Ear Canal Monitors Heart Health in Real Time

By HospiMedica International staff writers
Posted on 17 Jan 2024

Wearables such as smartwatches that are capable of monitoring functions can provide details of an individual’s heartbeat but cannot accurately and unobtrusively measure the electrical current of the heart, which can help diagnose an irregular heartbeat. More...

Now, a study has shown for the first time that tiny devices, situated in a single ear, can effectively capture electrocardiogram (ECG) data in real time. This innovation marks a significant advancement toward monitoring heart health more precisely.

The research, conducted by a team at Imperial College London (London, UK), builds on their previous work where they identified the ear as a viable location for monitoring brain functions and vital signs through "hearable devices" – wearables that fit comfortably within the ear canal. The team also pioneered an ear-ECG technology, where electrodes placed in both ears can generate valid electrocardiograms. This new study, however, explored the potential of using hearables for cardiac health monitoring from just one ear, a concept not yet thoroughly established. To validate their approach, the Imperial College team examined ECG signals and mapped the chest-ECG potential across the ear, neck, and scalp areas. They then tested the feasibility of single ear-ECG measurements under real-world recording conditions.

The study successfully measured cardiac cycles using electrodes placed around the ear region, confirming the accuracy of ECG signals obtained from a single ear-ECG in terms of their shape and timing. The researchers envision that this technology could eventually be used for continuous 24/7 monitoring of various groups such as patients and athletes. It could also be employed to assess the impact of physical strain and stress in different workplace environments, offering a more non-invasive and continuous method of monitoring heart health.

“The significance of our findings lies in the high practicality and usability of the single ear-ECG,” said Metin Yarici, lead author of the study. “We believe that this method holds great promise in bringing continuous cardiac motoring out of a clinical setting and into society, and with it, new insights into heart functioning for healthy and patient populations alike. An important next step in this research is to test the feasibility of detecting specific abnormalities in heart function, such as atrial fibrillation or myocardial infarction, via the single ear-ECG.”

Related Links:
Imperial College London


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.